Dr. Gertler provides counsel and analysis on franchise and therapeutic-area strategies, and corporate and business development activities. In addition, he advises clients on planning and execution of value-creating transactions across the spectrum of size and stage in the life sciences and medtech. His practice encompasses North American and European public and private commercial-stage and R&D-stage companies from mid to large cap; venture-backed companies; and investment firms focused on the life sciences.

Prior to founding Back Bay, Dr. Gertler served as Senior Partner and Managing Director of Leerink Swann Strategic Advisors, the consulting arm of Leerink Swann. He also led several investment banking groups: BioPharma Investment Banking at Leerink Swann and Health Care Investment Banking at Adams Harkness/Canaccord Adams. In this capacity, he advised on a significant number of equity, partnering and M&A transactions that total multi-billions in aggregate consideration.